HEALTH AND SAFETY

» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing

 

More Information on Celecoxib (Celebrex)

More information on meloxicam (Mobic)

More information on rofecoxib (Vioxx)

More Information on valdecoxib (Bextra)

Letter in the New York Times on Cox-2 Painkillers: Painkillers and Terrorism

This Letter to the Editor by Sidney Wolfe, M.D. appeared in The New York Times on Saturday February 26, 2005

To the Editor:

Re "F.D.A. Is Advised to Let Pain Pills Stay on Market" (front page, Feb. 19):

At the recent F.D.A. hearings about cox-2 drugs, Dr. Christopher Grubb, a captain in the Army Medical Corps, stated that the widespread use of these drugs in the military is "essential for our global war on terrorism."

Given the lack of evidence that cox-2 drugs are more effective than older pain/arthritis drugs and that they cause significant risks of heart attacks and other cardiovascular disorders, why is the military jeopardizing the troops' health by using these drugs, and why is the F.D.A. ready to leave Celebrex and Bextra on the market and even consider remarketing Vioxx?

The most conservative estimate for Vioxx, based on its four-fold increased risk of heart attacks compared with naproxen, is that it caused, annually, thousands of extra heart attacks, many fatal, with additional heart attacks caused by Celebrex and Bextra. A growing number of physicians are rejecting the use of these drugs because of their unique risks. Perhaps Defense Secretary Donald H. Rumsfeld needs to talk with military physicians.

Sidney M. Wolfe, M.D.
Washington, Feb. 19, 2005

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.